Eleva Capital SAS
Latest statistics and disclosures from Eleva Capital SAS's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CRH, AS, NVDA, NFLX, GOOGL, and represent 91.56% of Eleva Capital SAS's stock portfolio.
- Added to shares of these 10 stocks: NVDA (+$9.1M), NFLX (+$8.2M), GOOGL (+$8.0M), TSM (+$6.5M), AS (+$6.2M), AMZN, TMUS, HOOD, ONON, BSX.
- Started 20 new stock positions in FCX, HOOD, TSM, EWTX, SPOT, CGON, NAMS, BSX, AQST, ACHR. NVDA, IRON, FENC, MLYS, GOOGL, TMUS, AMZN, ONON, VRDN, ESPR.
- Reduced shares in these 10 stocks: CRH (-$24M), MELI (-$6.0M), MSFT, AU, KGC, PL, , PONY, DECK, COHR.
- Sold out of its positions in BMRN, COHR, DECK, FICO, KGC, MSCI, MELI, MSFT, PL, PONY. AU.
- Eleva Capital SAS was a net buyer of stock by $9.8M.
- Eleva Capital SAS has $343M in assets under management (AUM), dropping by -9.35%.
- Central Index Key (CIK): 0002054496
Tip: Access up to 7 years of quarterly data
Positions held by Eleva Capital SAS consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Eleva Capital SAS
Eleva Capital SAS holds 24 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| CRH Ord (CRH) | 81.3 | $279M | -7% | 2.7M | 105.12 |
|
| Amer Sports Com Shs (AS) | 2.9 | $9.8M | +171% | 299k | 32.92 |
|
| NVIDIA Corporation (NVDA) | 2.6 | $9.1M | NEW | 52k | 174.40 |
|
| Netflix (NFLX) | 2.4 | $8.4M | +5967% | 87k | 96.15 |
|
| Alphabet Cap Stk Cl A (GOOGL) | 2.3 | $8.0M | NEW | 28k | 287.56 |
|
| Taiwan Semiconductor Mfg Lt Sponsored Ads (TSM) | 1.9 | $6.5M | NEW | 21k | 303.89 |
|
| Arista Networks Com Shs (ANET) | 1.7 | $5.8M | +38% | 47k | 122.78 |
|
| Amazon (AMZN) | 1.0 | $3.4M | NEW | 16k | 208.27 |
|
| Metropcs Communications (TMUS) | 0.9 | $3.0M | NEW | 14k | 210.03 |
|
| Robinhood Mkts Com Cl A (HOOD) | 0.6 | $2.2M | NEW | 32k | 69.30 |
|
| On Hldg Namen Akt A (ONON) | 0.5 | $1.7M | NEW | 50k | 34.02 |
|
| Boston Scientific Corporation (BSX) | 0.5 | $1.7M | NEW | 27k | 62.75 |
|
| Spotify Technology S A SHS (SPOT) | 0.4 | $1.3M | NEW | 2.7k | 484.91 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.2 | $823k | NEW | 26k | 32.01 |
|
| Cg Oncology (CGON) | 0.2 | $561k | NEW | 8.3k | 67.68 |
|
| Esperion Therapeutics (ESPR) | 0.1 | $502k | NEW | 183k | 2.74 |
|
| Mineralys Therapeutics (MLYS) | 0.1 | $463k | NEW | 17k | 27.09 |
|
| Fennec Pharmaceuticals (FENC) | 0.1 | $327k | NEW | 53k | 6.15 |
|
| Disc Medicine (IRON) | 0.1 | $327k | NEW | 5.1k | 63.94 |
|
| Miragen Therapeutics (VRDN) | 0.0 | $139k | NEW | 7.1k | 19.56 |
|
| Freeport Mcmoran CL B (FCX) | 0.0 | $133k | NEW | 2.3k | 58.78 |
|
| Archer Aviation Com Cl A (ACHR) | 0.0 | $111k | NEW | 22k | 5.17 |
|
| Edgewise Therapeutics (EWTX) | 0.0 | $55k | NEW | 18k | 3.15 |
|
| Aquestive Therapeutics (AQST) | 0.0 | $11k | NEW | 2.7k | 4.15 |
|
Past Filings by Eleva Capital SAS
SEC 13F filings are viewable for Eleva Capital SAS going back to 2025
- Eleva Capital SAS 2026 Q1 filed April 15, 2026
- Eleva Capital SAS 2025 Q3 filed Nov. 10, 2025
- Eleva Capital SAS 2025 Q2 filed Aug. 5, 2025